8-K Announcements
6May 5, 2026·SEC
May 4, 2026·SEC
Feb 24, 2026·SEC
Diversified Healthcare Trust (DHC) fundamental analysis — strengths, weaknesses & financial health based on data analysis
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Diversified Healthcare Trust (DHC) stock price & volume — 10-year historical chart
Diversified Healthcare Trust (DHC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Diversified Healthcare Trust (DHC) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 4, 2026 | $0.18vs $0.15-22.7% | $366Mvs $380M-3.6% |
| Q1 2026 | Feb 23, 2026 | $0.09vs $0.15+160.0% | $380Mvs $393M-3.4% |
| Q4 2025 | Nov 3, 2025 | $0.04vs $0.08-50.0% | $389Mvs $393M-1.1% |
| Q3 2025 | Aug 4, 2025 | $0.08vs $0.08+0.0% | $383Mvs $382M+0.2% |
Diversified Healthcare Trust (DHC) competitors in Diversified healthcare real estate — business model, growth, and fundamentals comparison
Diversified Healthcare Trust (DHC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Diversified Healthcare Trust (DHC) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.07B | 1.12B | 1.04B | 1.63B | 1.38B | 1.28B | 1.41B | 1.5B | 1.54B | 1.52B |
| Revenue Growth % | 1.58% | 3.95% | -6.89% | 56.9% | -15.25% | -7.2% | 9.87% | 6.04% | 2.84% | 0.39% |
| Property Operating Expenses | 413.89M | 451.77M | 502.17M | 1.24B | 1.09B | 1.11B | 1.19B | 1.24B | 1.78B | 1.49B |
| Net Operating Income (NOI) | 660.83M▲ 0% | 665.39M▲ 0.7% | 537.98M▼ 19.1% | 394.86M▼ 26.6% | 291.4M▼ 26.2% | 174.5M▼ 40.1% | 225.3M▲ 29.1% | 256.38M▲ 13.8% | -245.33M▼ 195.7% | 32.05M▲ 0% |
| NOI Margin % | 61.49% | 59.56% | 51.72% | 24.19% | 21.07% | 13.59% | 15.98% | 17.14% | -15.95% | 2.11% |
| Operating Expenses | 103.69M | 85.89M | 37.03M | 30.59M | 305.22M | 265.71M | 26.13M | 26.52M | -206.06M | 70M |
| G&A Expenses | 103.69M | 85.89M | 37.03M | 30.59M | 34.09M | 26.43M | 26.13M | 26.52M | 45.5M | 36.5M |
| EBITDA | 828.65M | 859.95M | 783.19M | 627M | 257.31M | 148.31M | 483.01M | 514.92M | 222.66M | 218.62M |
| EBITDA Margin % | 77.1% | 76.98% | 75.3% | 38.42% | 18.6% | 11.55% | 34.25% | 34.43% | 14.48% | 14.41% |
| Depreciation & Amortization | 271.51M | 280.45M | 282.23M | 262.74M | 271.13M | 239.53M | 283.84M | 285.06M | 261.92M | 256.57M |
| D&A / Revenue % | 25.26% | 25.1% | 27.13% | 16.1% | 19.6% | 18.66% | 20.13% | 19.06% | 17.03% | 16.91% |
| Operating Income | 557.14M▲ 0% | 579.5M▲ 4.0% | 500.95M▼ 13.6% | 364.26M▼ 27.3% | -13.82M▼ 103.8% | -91.22M▼ 560.1% | 199.17M▲ 318.3% | 229.86M▲ 15.4% | -39.27M▼ 117.1% | -37.95M▲ 0% |
| Operating Margin % | 51.84% | 51.87% | 48.16% | 22.32% | -1% | -7.11% | 14.12% | 15.37% | -2.55% | -2.5% |
| Interest Expense | 165.02M | 179.29M | 180.11M | 201.48M | 255.76M | 209.38M | 191.78M | 235.24M | 204.5M | 4M |
| Interest Coverage | 1.70x | 1.64x | 1.18x | 0.47x | 1.71x | 0.90x | -0.44x | -0.23x | -0.39x | - |
| Non-Operating Income | 276.86M | 286.24M | 289.02M | 270.15M | -450.93M | -279.48M | 284.08M | 284.96M | 40.38M | 55.49M |
| Pretax Income | 152.26M▲ 0% | 292.89M▲ 92.4% | -82.44M▼ 128.1% | -133.06M▼ 61.4% | 181.36M▲ 236.3% | -15.06M▼ 108.3% | -293.13M▼ 1845.9% | -369.79M▼ 26.2% | -284.14M▲ 23.2% | -317.86M▲ 0% |
| Pretax Margin % | 14.17% | 26.22% | -7.93% | -8.15% | 13.11% | -1.17% | -20.78% | -24.73% | -18.48% | -20.95% |
| Income Tax | 454K | 476K | 436K | 1.25M | 1.43M | 710K | 445K | 467K | 1.74M | 2.32M |
| Effective Tax Rate % | 0.3% | 0.16% | -0.53% | -0.94% | 0.79% | -4.71% | -0.15% | -0.13% | -0.61% | -0.73% |
| Net Income | 147.61M▲ 0% | 286.87M▲ 94.3% | -88.23M▼ 130.8% | -139.45M▼ 58.0% | 174.51M▲ 225.1% | -15.77M▼ 109.0% | -293.57M▼ 1761.1% | -370.25M▼ 26.1% | -285.89M▲ 22.8% | -320.18M▲ 0% |
| Net Margin % | 13.73% | 25.68% | -8.48% | -8.54% | 12.62% | -1.23% | -20.82% | -24.76% | -18.59% | -21.1% |
| Net Income Growth % | 4.47% | 94.34% | -130.76% | -58.05% | 225.14% | -109.04% | -1761.11% | -26.12% | 22.79% | -9.28% |
| Funds From Operations (FFO) | 419.12M▲ 0% | 567.32M▲ 35.4% | 194M▼ 65.8% | 123.29M▼ 36.4% | 445.65M▲ 261.5% | 223.75M▼ 49.8% | -9.73M▼ 104.3% | -85.19M▼ 775.5% | -23.96M▲ 71.9% | -63.61M▲ 0% |
| FFO Margin % | 39% | 50.78% | 18.65% | 7.55% | 32.22% | 17.43% | -0.69% | -5.7% | -1.56% | -4.19% |
| FFO Growth % | -1.19% | 35.36% | -65.8% | -36.45% | 261.46% | -49.79% | -104.35% | -775.47% | 71.87% | 226.17% |
| FFO per Share | 1.77 | 2.39 | 0.82 | 0.52 | 1.87 | 0.94 | -0.04 | -0.36 | -0.10 | -0.26 |
| FFO Payout Ratio % | 88.42% | 65.35% | 102.95% | 34.74% | 2.14% | 4.28% | -98.6% | -11.3% | -40.32% | -11.4% |
| EPS (Diluted) | 0.62▲ 0% | 1.21▲ 95.2% | -0.37▼ 130.6% | -0.59▼ 59.5% | 0.73▲ 223.7% | -0.07▼ 109.1% | -1.23▼ 1758.0% | -1.55▼ 26.0% | -1.19▲ 23.2% | -1.33▲ 0% |
| EPS Growth % | 3.33% | 95.16% | -130.58% | -59.46% | 223.73% | -109.07% | -1758.01% | -26.02% | 23.23% | -9.11% |
| EPS (Basic) | 0.62 | 1.21 | -0.37 | -0.59 | 0.73 | -0.07 | -1.23 | -1.55 | -1.19 | - |
| Diluted Shares Outstanding | 237.45M | 237.55M | 237.6M | 237.74M | 237.97M | 238.31M | 238.84M | 239.53M | 240.29M | 240.69M |
Diversified Healthcare Trust (DHC) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 7.29B | 7.16B | 6.65B | 6.48B | 6.62B | 6B | 5.45B | 5.14B | 4.36B | 4.27B |
| Asset Growth % | 0.92% | -1.83% | -7.07% | -2.67% | 2.27% | -9.38% | -9.26% | -5.68% | -15.1% | -51.87% |
| Real Estate & Other Assets | -7.05B | -6.97B | 6.05B | 87.97M | 149.12M | 5.1B | 4.92B | 4.53B | 129.89M | 0 |
| PP&E (Net) | 6.37B | 6.34B | 0 | 5.72B | 5.08B | 0 | 23.37M | 0 | 16.54M | 0 |
| Investment Securities | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 |
| Total Current Assets | 47.32M | 70.07M | 263.78M | 308.09M | 1.1B | 697.4M | 262.49M | 430.18M | 187.93M | 121.77M |
| Cash & Equivalents | 31.24M | 54.98M | 37.36M | 74.42M | 634.85M | 658.07M | 245.94M | 144.58M | 121.8M | 121.77M |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 |
| Other Current Assets | 16.08M | 17.02M | 224.44M | 128.87M | 382.1M | 30.62M | 10.47M | 281.54M | 0 | 0 |
| Intangible Assets | 472.26M | 419.24M | 337.88M | 286.51M | 48.75M | 45.35M | 33.95M | 26.3M | 20.66M | 19.56M |
| Total Liabilities | 4.02B | 3.98B | 3.78B | 3.86B | 3.96B | 3.36B | 3.11B | 3.18B | 2.7B | 2.65B |
| Total Debt | 3.77B | 3.73B | 3.58B | 3.5B | 3.68B | 3.08B | 2.82B | 2.91B | 2.42B | 0 |
| Net Debt | 3.74B | 3.68B | 3.54B | 3.43B | 3.05B | 2.42B | 2.57B | 2.77B | 2.3B | -121.77M |
| Long-Term Debt | 3.67B | 3.2B | 2.27B | 3.19B | 3.67B | 2.35B | 2.82B | 2.91B | 2.4B | 0 |
| Short-Term Borrowings | 0 | 446.14M | 537.5M | 299.27M | 0 | 700M | 0 | 0 | 1.87M | 0 |
| Capital Lease Obligations | 96.02M | 86.3M | 771.44M | 12.22M | 10.99M | 30.18M | 0 | 0 | 18.34M | 38.52M |
| Total Current Liabilities | 613.99M | 165.18M | 577.1M | 326.57M | 29.84M | 734.62M | 29.94M | 38.1M | 1.87M | 0 |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 4.02B | 3.98B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | -367.7M | 526.79M | 158.81M | 326.68M | 250.4M | 250.81M | 262.46M | 229.15M | 277.74M | 2.65B |
| Total Equity | 3.45B▲ 0% | 3.34B▼ 3.3% | 2.88B▼ 13.8% | 2.62B▼ 9.0% | 2.66B▲ 1.6% | 2.64B▼ 0.9% | 2.34B▼ 11.4% | 1.96B▼ 16.2% | 1.67B▼ 15.0% | 1.62B▲ 0% |
| Equity Growth % | -50.61% | -3.27% | -13.77% | -8.96% | 1.65% | -0.89% | -11.43% | -16.18% | -14.97% | -63.04% |
| Shareholders Equity | 3.28B | 3.18B | 2.74B | 2.5B | 2.66B | 2.64B | 2.34B | 1.96B | 1.67B | 1.62B |
| Minority Interest | 172.24M | 156.76M | 140.53M | 123.39M | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 2.38M | 2.38M | 2.38M | 2.38M | 2.39M | 2.4M | 2.4M | 2.41M | 2.42M | 2.42M |
| Additional Paid-in Capital | 4.61B | 4.61B | 4.61B | 4.61B | 4.62B | 4.62B | 4.62B | 4.62B | 4.62B | 0 |
| Retained Earnings | -1.59B | -1.59B | -1.88B | 0 | 0 | -1.98B | -2.28B | -2.66B | -2.96B | 0 |
| Preferred Stock | 172.24M | 156.76M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Return on Assets (ROA) | 2.03% | 3.97% | -1.28% | -2.12% | 2.66% | -0.25% | -5.13% | -7% | -6.02% | -7.09% |
| Return on Equity (ROE) | 2.83% | 8.45% | -2.84% | -5.07% | 6.61% | -0.6% | -11.8% | -17.24% | -15.78% | -18.75% |
| Debt / Assets | 51.69% | 52.16% | 53.78% | 54.09% | 55.57% | 51.28% | 51.72% | 56.67% | 55.44% | 0% |
| Debt / Equity | 1.09x | 1.12x | 1.24x | 1.34x | 1.38x | 1.17x | 1.21x | 1.49x | 1.45x | 1.45x |
| Net Debt / EBITDA | 4.51x | 4.28x | 4.52x | 5.47x | 11.84x | 16.32x | 5.32x | 5.37x | 10.31x | 10.31x |
| Book Value per Share | 14.53 | 14.05 | 12.11 | 11.02 | 11.19 | 11.07 | 9.78 | 8.18 | 6.93 | 6.73 |
Diversified Healthcare Trust (DHC) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 407.05M | 392.84M | 265.85M | 158.54M | -63.32M | -40.35M | 10.48M | 112.22M | -19.62M | -19.62M |
| Operating CF Growth % | -4.63% | -3.49% | -32.33% | -40.36% | -139.94% | 36.27% | 125.98% | 970.52% | -117.48% | -166.79% |
| Operating CF / Revenue % | 37.87% | 35.16% | 25.56% | 9.71% | -4.58% | -3.14% | 0.74% | 7.5% | -1.28% | -1.29% |
| Net Income | 151.8M | 292.41M | -82.88M | -134.31M | 179.93M | -15.77M | -293.57M | -370.25M | -285.89M | -320.18M |
| Depreciation & Amortization | 271.51M | 280.45M | 282.23M | 262.74M | 263.92M | 239.53M | 283.84M | 285.06M | 262.04M | 256.6M |
| Stock-Based Compensation | 2.15M | 2.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -46.4M | -183.12M | 117.37M | 43.28M | -442.05M | -265.74M | 48.05M | 190.6M | -29.03M | 35.78M |
| Working Capital Changes | 30.14M | 3.1M | -50.88M | -13.18M | -65.12M | 1.64M | -27.84M | 6.82M | 33.26M | 19.76M |
| Cash from Investing | -221.44M | 99.09M | 86.17M | -40.44M | 242.7M | 387.71M | -202.11M | -187.02M | 483.57M | 206.06M |
| Acquisitions (Net) | 255.93M | 0 | 0 | 0 | 367.03M | 108.42M | 0 | -21.18M | 0 | -2.7M |
| Purchase of Investments | -159.29M | -129.49M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sale of Investments | 55.07M | 332.39M | 98.56M | 0 | 0 | 0 | 0 | 0 | 0 | 48.89M |
| Other Investing | -221.44M | 99.09M | -12.39M | -40.44M | -124.34M | 279.28M | -202.11M | -165.84M | 483.57M | 195.03M |
| Cash from Financing | -186.13M | -469.18M | -369.86M | -79.48M | 746.72M | -676M | -249.71M | -22.31M | -492.01M | -364.83M |
| Dividends Paid | -370.61M | -370.75M | -199.72M | -42.83M | -9.54M | -9.57M | -9.6M | -9.63M | -9.66M | -9.67M |
| Common Dividends | -370.61M | -370.75M | -199.72M | -42.83M | -9.54M | -9.57M | -9.6M | -9.63M | -9.66M | -7.25M |
| Debt Issuance (Net) | -1000K | -1000K | -1000K | -1000K | 1000K | -1000K | -1000K | -1000K | -1000K | -2M |
| Share Repurchases | -341K | -411K | -299K | -171K | -383K | -171K | -393K | -904K | -1.15M | -1.23M |
| Other Financing | 229.79M | -25.47M | -22M | -28.05M | -32.7M | -27.19M | -22.68M | -8.56M | -37.66M | -30.66M |
| Net Change in Cash | -511K▲ 0% | 22.75M▲ 4552.1% | -17.85M▼ 178.4% | 38.63M▲ 316.4% | 926.1M▲ 2297.7% | -328.64M▼ 135.5% | -441.34M▼ 34.3% | -97.11M▲ 78.0% | -28.05M▲ 71.1% | -166.8M▲ 0% |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 31.75M | 47.32M | 70.07M | 52.22M | 90.85M | 1.02B | 688.3M | 246.96M | 149.85M | 121.8M |
| Cash at End | 31.24M | 70.07M | 52.22M | 90.85M | 1.02B | 688.3M | 246.96M | 149.85M | 121.8M | 139.85M |
| Free Cash Flow | 185.62M▲ 0% | 491.93M▲ 165.0% | 265.85M▼ 46.0% | 158.54M▼ 40.4% | -63.32M▼ 139.9% | -40.35M▲ 36.3% | 10.48M▲ 126.0% | 112.22M▲ 970.5% | -19.62M▼ 117.5% | -43.2M▲ 0% |
| FCF Growth % | 38.58% | 165.03% | -45.96% | -40.36% | -139.94% | 36.27% | 125.98% | 970.52% | -117.48% | -153.74% |
| FCF / Revenue % | 17.27% | 44.03% | 25.56% | 9.71% | -4.58% | -3.14% | 0.74% | 7.5% | -1.28% | -2.85% |
Diversified Healthcare Trust (DHC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| FFO per Share | 1.77 | 2.39 | 0.82 | 0.52 | 1.87 | 0.94 | -0.04 | -0.36 | -0.1 | -0.26 |
| FFO Payout Ratio | 88.42% | 65.35% | 102.95% | 34.74% | 2.14% | 4.28% | -98.6% | -11.3% | -40.32% | -11.4% |
| NOI Margin | 61.49% | 59.56% | 51.72% | 24.19% | 21.07% | 13.59% | 15.98% | 17.14% | -15.95% | 2.11% |
| Net Debt / EBITDA | 4.51x | 4.28x | 4.52x | 5.47x | 11.84x | 16.32x | 5.32x | 5.37x | 10.31x | 10.31x |
| Debt / Assets | 51.69% | 52.16% | 53.78% | 54.09% | 55.57% | 51.28% | 51.72% | 56.67% | 55.44% | 0% |
| Interest Coverage | 1.70x | 1.64x | 1.18x | 0.47x | 1.71x | 0.90x | -0.44x | -0.23x | -0.39x | - |
| Book Value / Share | 14.53 | 14.05 | 12.11 | 11.02 | 11.19 | 11.07 | 9.78 | 8.18 | 6.93 | 6.73 |
| Revenue Growth | 1.58% | 3.95% | -6.89% | 56.9% | -15.25% | -7.2% | 9.87% | 6.04% | 2.84% | 0.39% |
Diversified Healthcare Trust (DHC) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 5, 2026·SEC
May 4, 2026·SEC
Feb 24, 2026·SEC
Diversified Healthcare Trust (DHC) stock FAQ — growth, dividends, profitability & financials explained
Diversified Healthcare Trust (DHC) reported $1.52B in revenue for fiscal year 2025. This represents a 1618% increase from $88.3M in 1998.
Diversified Healthcare Trust (DHC) grew revenue by 2.8% over the past year. Growth has been modest.
Diversified Healthcare Trust (DHC) reported a net loss of $320.2M for fiscal year 2025.
Yes, Diversified Healthcare Trust (DHC) pays a dividend with a yield of 0.48%. This makes it attractive for income-focused investors.
Diversified Healthcare Trust (DHC) has a return on equity (ROE) of -15.8%. Negative ROE indicates the company is unprofitable.
Diversified Healthcare Trust (DHC) generated Funds From Operations (FFO) of $-63.6M in the trailing twelve months. FFO is the primary profitability metric for REITs.
Diversified Healthcare Trust (DHC) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates